Skip to Content
Developmental Therapeutics Program (DTP)
Last Updated: 03/02/16

Jerry M. Collins, Ph.D.

Dr. Jerry M. Collins, Associate Director

Associate Director

Developmental Therapeutics Program

Developmental Therapeutics Program
Division of Cancer Treatment and Diagnosis
National Cancer Institute
NCI Shady Grove
9609 Medical Center Drive, Rm 4W632, MSC 9735
Bethesda, MD 20892-9735
Rockville, MD 20850 (for courier delivery)
240-276-5949
collinsje@mail.nih.gov

Jerry M. Collins, Ph.D., is an internationally recognized pharmacologist. He has been closely associated with NCI’s drug development efforts for more than 25 years, first as an NCI intramural investigator and then as the Chief of the Pharmacokinetics Section. From 1988 until 2005, Dr. Collins served as the Director of the FDA’s Laboratory of Clinical Pharmacology, where he headed the development of new methods to facilitate research on human tissue metabolism to create an in vitro model to reduce adverse drug reactions. Dr. Collins was named Associate Director of the DCTD Developmental Therapeutics Program in September 2005.

Dr. Collins’ areas of expertise are clinical pharmacology, the application of pharmacokinetic and pharmacodynamic principles to cancer research, and increasing biomarker efficacy with positron emission tomography.

Dr. Collins received his bachelor’s degree from Drexel University and his master’s and doctoral degrees from the University of Pennsylvania. He is the author or co-author of more than 170 articles and holds eight patents.

About the
Associate Director

Jerry M. Collins, Ph.D. Jerry M. Collins, Ph.D., is an internationally recognized pharmacologist. He has been closely associated with NCI’s drug development efforts for more than 25 years, first as an NCI intramural investigator and then as the Chief of the Pharmacokinetics Section. More…